Cardinal Health Biosimilar Products

Listing Websites about Cardinal Health Biosimilar Products

Filter Type:

Biosimilars Cardinal Health

(2 days ago) WebBiosimilars — a fast-growing class of therapeutic products that are highly similar to and have no clinically meaningful differences from existing FDA-approved branded biologics—are poised to significantly change the face of medicine in oncology, …

https://www.cardinalhealth.com/en/product-solutions/pharmaceutical-products/biosimilars.html

Category:  Medicine Show Health

New and upcoming biosimilar launches - Cardinal Health

(8 days ago) WebInfliximab. RemicadeTM (Janssen) Avsola Amgen Jul 2020. Ustekinumab. StelaraTM (Janssen) Wezlana. Amgen. FDA approved, anticipated to launch in Jan 2025.

https://www.cardinalhealth.com/content/dam/corp/web/documents/Report/cardinal-health-biosimilar-launches.pdf

Category:  Health Show Health

Biosimilars resources - Cardinal Health

(3 days ago) WebLearning biosimilar use from other countries. Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discusses lessons that can be learned from …

https://www.cardinalhealth.com/en/product-solutions/pharmaceutical-products/biosimilars/biosimilars-resource.html

Category:  Health Show Health

Insights on a pivotal year of evolution and expansion

(2 days ago) WebCardinal Health remains unwavering in our commitment to fostering the development and adoption of biosimilars. Together, we can continue to drive progress and innovation in …

https://www.cardinalhealth.com/content/dam/corp/web/documents/Report/cardinal-health-2024-Biosimilars-Report.pdf

Category:  Health Show Health

Changing Biosimilars landscape 2023 - Cardinal Health News

(1 days ago) WebJanuary 2023 represented a watershed moment for the biosimilars market as the first adalimumab biosimilar launched commercially in the U.S. after originally …

https://newsroom.cardinalhealth.com/2023-03-03-The-changing-biosimilars-landscape

Category:  Health Show Health

Cardinal Health annual research report examines milestone year in

(4 days ago) WebDUBLIN, Ohio, Feb. 29, 2024 / PRNewswire / -- Today, Cardinal Health (NYSE: CAH) released its 2024 Biosimilars Report: insights on a pivotal year of evolution and …

https://newsroom.cardinalhealth.com/2024-02-29-Cardinal-Health-annual-research-report-examines-milestone-year-in-biosimilars

Category:  Health Show Health

New Cardinal Health report examines shifts in biosimilars industry

(3 days ago) WebAbout Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider …

https://newsroom.cardinalhealth.com/2023-02-22-New-Cardinal-Health-report-examines-shifts-in-biosimilars-industry

Category:  Medical Show Health

Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in

(3 days ago) WebDUBLIN, Ohio, Feb. 7, 2022 /PRNewswire/ -- Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings …

https://newsroom.cardinalhealth.com/2022-02-07-Cardinal-Health-Predicts-2022-to-be-Turning-Point-for-Biosimilars-in-the-U-S

Category:  Health Show Health

New Cardinal Health report examines shifts in biosimilars industry

(2 days ago) WebCardinal Health announces location of pharmaceutical distribution center for over-the-counter products . Today, Cardinal Health (NYSE: CAH) announced that …

https://www.prnewswire.com/news-releases/new-cardinal-health-report-examines-shifts-in-biosimilars-industry-301752744.html

Category:  Health Show Health

Cardinal Health News & Media - Cardinal Health Latest News

(1 days ago) WebA: Biologics are the most expensive medicines in the U.S. For a patient managing a complex disease or diseases, biologics can cost tens of thousands of dollars …

https://newsroom.cardinalhealth.com/2021-11-3-An-introduction-to-biosimilars-Medications-that-drive-competition,-lower-costs-and-increase-accessibility

Category:  Medicine Show Health

Cardinal Health annual research report examines milestone year in

(3 days ago) WebDUBLIN, Ohio, Feb. 29, 2024 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH ) released its 2024 Biosimilars Report: insights on a pivotal year of evolution and …

https://www.prnewswire.com/news-releases/cardinal-health-annual-research-report-examines-milestone-year-in-biosimilars-302075391.html

Category:  Health Show Health

Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in

(1 days ago) WebDUBLIN, Ohio, Feb. 7, 2022 /PRNewswire/ -- Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings …

https://www.prnewswire.com/news-releases/cardinal-health-predicts-2022-to-be-turning-point-for-biosimilars-in-the-us-301476008.html

Category:  Health Show Health

Cardinal Health Biosimilars 2022

(6 days ago) WebCardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for …

https://newsroom.cardinalhealth.com/latest-news?item=121

Category:  Medical Show Health

Cardinal Health Exec: How Adalimumab Biosimilars Can Reshape …

(9 days ago) WebFran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health, published her opinions on the future of biosimilars in the United …

https://www.centerforbiosimilars.com/view/cardinal-health-exec-how-adalimumab-biosimilars-can-reshape-the-us-health-care-industry

Category:  Health Show Health

Cardinal Health Releases 2023 Biosimilars Report - Drug Topics

(Just Now) WebWhile 2022 might have been a turning point for biosimilars, 2023 is expected to bring more disruption, according to a new report from Cardinal Health.The …

https://www.drugtopics.com/view/cardinal-health-releases-2023-biosimilars-report

Category:  Health Show Health

Biosimilars Report Cardinal Health

(1 days ago) WebCardinal Health analyzes a year of monumental developments in biosimilars, offering expert commentary and provider perspectives on a rapidly changing industry landscape …

https://www.cardinalhealth.com/en/product-solutions/pharmaceutical-products/biosimilars/biosimilars-report.html

Category:  Health Show Health

Cardinal Health Report Showcases Biosimilar Growth, Provider and …

(Just Now) WebIn its 2024 Biosimilars Report, Cardinal Health analyzed key economic and legislative developments in the biosimilar space, highlighting new treatment options, such as …

https://www.centerforbiosimilars.com/view/cardinal-health-report-showcases-biosimilar-growth-provider-and-payer-evolution-and-more

Category:  Health Show Health

FDA Roundup: April 26, 2024 FDA

(7 days ago) WebThis week, the FDA approved the 50th biosimilar, reflecting the markedly increased availability of biosimilar products—products that treat a wide range of …

https://www.fda.gov/news-events/press-announcements/fda-roundup-april-26-2024

Category:  Health Show Health

FDA Roundup: April 26, 2024 - PR Newswire

(1 days ago) WebThis week, the FDA approved the 50th biosimilar, reflecting the markedly increased availability of biosimilar products—products that treat a wide range of …

https://www.prnewswire.com/news-releases/fda-roundup-april-26-2024-302128950.html

Category:  Health Show Health

Cigna’s Evernorth to Offer Humira Biosimilar with No Out

(5 days ago) WebPictured: Cigna Group signage outside its office in Connecticut/iStock, JHVEPhoto Cigna subsidiary Evernorth Health Services announced on Thursday that it …

https://www.biospace.com/article/cigna-s-evernorth-to-offer-humira-biosimilar-with-no-out-of-pocket-cost/

Category:  Health Show Health

Cardinal Health releases 2023 Biosimilars Report

(6 days ago) WebDon’t miss out on any of our healthcare reporting: Subscribe today. Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and …

https://newsroom.cardinalhealth.com/latest-news?item=243

Category:  Medical Show Health

Cardinal Health Piscataway, NJ - Macrae's Blue Book

(5 days ago) WebCardinal Health. Address: 371 Hoes Ln # 300. Piscataway, NJ , 08854-4143. Phone: 732-465-1501. Website: cardinal.com. Contact this Company. This company is located in the …

https://www.macraesbluebook.com/search/company.cfm?company=466109

Category:  Health Show Health

We're reading about Cigna biosimilar, Vertex deal in South Africa

(6 days ago) WebThe World Health Organization says new evidence shows the extensive overuse of antibiotics during the Covid-19 pandemic worldwide. the move should save …

https://www.statnews.com/pharmalot/2024/04/26/cigna-biosimilar-humira-abbvie-vertex-medicines-africa-gsk-pfizer-biontech-vaccines-covid-bristol-layoffs-medicare-cardinal-who-antibiotics/

Category:  Health Show Health

Cardinal Health - Somerset, New Jersey (NJ) - BiosciRegister

(7 days ago) WebProfile: Cardinal Health offers technologies & services to the pharmaceutical, biotechnology and consumer healthcare industry.We offer softgel technology, fast dissolve …

https://www.biosciregister.com/Cardinal_Health/Supplier/sid1122.htm

Category:  Health Show Health

US FDA sends warning letter to Cardinal Health for marketing …

(7 days ago) WebThe U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois found the company was marketing and distributing …

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-sends-warning-cardinal-health-marketing-unapproved-devices-2024-04-25/

Category:  Health Show Health

Drug distributor Cardinal Health to lose OptumRx contracts

(9 days ago) WebThe Optum contracts, signed in 2015, contributed 16% of Cardinal's total revenue in fiscal year 2023, but the bulk of the shipments mainly comprised non …

https://www.reuters.com/business/healthcare-pharmaceuticals/cardinal-health-says-contracts-with-unitedhealths-optumrx-will-not-be-renewed-2024-04-22/

Category:  Health Show Health

Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance …

(6 days ago) WebDUBLIN, Ohio, April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which …

https://newsroom.cardinalhealth.com/2024-04-22-Cardinal-Health-Reaffirms-Fiscal-2024-non-GAAP-EPS-Guidance-and-Long-term-Targets-Amidst-Nonrenewal-of-OptumRx-Customer-Contracts

Category:  Health Show Health

Cardinal Health - 679404 - 04/24/2024 FDA

(Just Now) WebDuring an inspection of your firm Cardinal Health 200, LLC., located at 3651 Birchwood Dr., Waukegan, Illinois 60085 on December 11-20, 2023, an investigator from …

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cardinal-health-679404-04242024

Category:  Health Show Health

Our Locations Cardinal Health

(1 days ago) WebBy providing your phone number you are providing consent to receive direct text message communications from Cardinal Health for the purposes of recruiting. You may opt-out of …

https://jobs.cardinalhealth.com/locations/locations

Category:  Health Show Health

Kangaroo OMNI™ Enteral Feeding Pump Cardinal Health

(4 days ago) WebCardinal Health™ Brand Products Cardinal Health™ Brand Products; Clinical Chemistry Clinical Chemistry; General Lab General Lab; Improving biosimilar …

https://www.cardinalhealth.com/en/product-solutions/medical/enteral-feeding/kangaroo-omni-enteral-feeding-pump/kangaroo-omni-pump.html

Category:  Health Show Health

Neurontin Antitrust Litigation - Garwin Gerstein & Fisher LLP

(Just Now) WebServing as co-lead counsel, Garwin Gerstein & Fisher LLP achieved a $190 million recovery for the Direct Purchaser Class. Direct purchasers claimed that Pfizer violated federal …

https://garwingerstein.com/settlements/neurontin-antitrust-litigation/

Category:  Health Show Health

Filter Type: